Latest news from Embody, Inc. on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/embody-inc-announces-fda-510-k-clearance-of-tapestry-biointegrative-implant-for-tendon-and-ligament-repair/?sc=rsin /articles/embody-inc-announces-fda-510-k-clearance-of-tapestry-biointegrative-implant-for-tendon-and-ligament-repair/?sc=rsin Thu, 22 Oct 2020 08:55:43 EST Embody, Inc., a privately-held medical device company developing novel collagen-based technologies for sports medicine and soft tissue repair, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TAPESTRY Biointegrative Implant for tendon and ligament repair. Embody, Inc.